Suprachoroidal triamcinolone acetonide improves vision in patients with macular edema

Patients with macular edema secondary to noninfectious uveitis who were treated with suprachoroidally injected triamcinolone acetonide gained significantly more vision when compared with a sham-treated cohort.
“This phase 3 randomized controlled trial demonstrated that suprachoroidally administered corticosteroid was effective in the reduction of macular edema in patients with noninfectious uveitis with nearly 50% of patients experiencing significant visual acuity gain. In addition, the safety results were favorable with a low rate of cataract and intraocular pressure response. These

Full Story →